{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:27:56Z","timestamp":1786645676320,"version":"build-2736575974"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to identify and prioritize gut microbiota-derived metabolite-associated host candidate targets in high-risk primary biliary cholangitis (PBC) through integrative multi-omics analysis and external validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differentially expressed genes between high-risk and low-risk PBC liver samples were identified using GSE79850. Gut microbiota-derived metabolite-host gene associations and PBC-related targets were obtained from gutMGene and the Open Targets Platform, respectively. Candidate genes were identified through integrative intersection analysis and ranked using an exploratory priority score. Human Liver Cell Atlas-based reference localization, immune signature analysis, and external validation using GSE119600 were performed to further characterize the candidate genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 163 differentially expressed genes were identified in GSE79850. Integrative analysis with gutMGene and the Open Targets Platform identified six core candidate genes: CCL2, CDKN1A, BCL2, CD44, FOS, and MAPK3. CCL2 showed the highest priority score, was associated with multiple gut microbiota-related metabolites, including acetate, butyrate, propionate, and succinate, and was significantly upregulated in high-risk PBC liver samples. Human Liver Cell Atlas-based reference localization showed that CCL2 was mainly distributed in immune-related cell populations, including macrophages and monocyte-derived cells. High-risk PBC samples exhibited increased chemokine signaling signature scores, and CCL2 expression was positively correlated with this signature. In the GSE119600 cohort, CD44, FOS, and CDKN1A were significantly upregulated in PBC samples compared with controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This integrative analysis identified six candidate host targets associated with high-risk PBC. CCL2 showed the most convergent evidence within the discovery framework and may represent a chemokine-related hepatic microenvironment-associated candidate target. In contrast, CD44, FOS, and CDKN1A showed supportive expression patterns in the GSE119600 blood cohort. These findings represent exploratory candidate prioritization, and further validation in independent liver tissue cohorts and experimental studies is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0356008","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:30:40Z","timestamp":1786642240000},"page":"e0356008","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative bioinformatics analysis identifies gut microbiota-derived metabolite-associated immune candidate targets in high-risk primary biliary cholangitis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7455-4667","authenticated-orcid":true,"given":"Jing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanna","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"1","key":"pone.0356008.ref001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0356008.ref002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American Association for the study of liver diseases","volume":"69","author":"KD Lindor","year":"2019","journal-title":"Hepatology"},{"key":"pone.0356008.ref003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ebiom.2016.11.021","article-title":"Early molecular stratification of high-risk primary biliary cholangitis","volume":"14","author":"C Hardie","year":"2016","journal-title":"EBioMedicine"},{"issue":"3","key":"pone.0356008.ref004","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"R Tang","year":"2018","journal-title":"Gut"},{"key":"pone.0356008.ref005","doi-asserted-by":"crossref","first-page":"1126117","DOI":"10.3389\/fimmu.2023.1126117","article-title":"Gut microbial profile of treatment-naive patients with primary biliary cholangitis","volume":"14","author":"Y-J Zhou","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0356008.ref006","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnab038","article-title":"Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis","volume":"368","author":"C Lammert","year":"2021","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"pone.0356008.ref007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13578-024-01253-1","article-title":"Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment","volume":"14","author":"W Han","year":"2024","journal-title":"Cell Biosci"},{"key":"pone.0356008.ref008","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab786","article-title":"gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites","volume":"50","author":"L Cheng","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"pone.0356008.ref009","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1046","article-title":"The next-generation Open Targets Platform: reimagined, redesigned, rebuilt","volume":"51","author":"D Ochoa","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0356008.ref010","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"SA MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"pone.0356008.ref011","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"T Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"pone.0356008.ref012","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"S Davis","year":"2007","journal-title":"Bioinformatics"},{"issue":"7","key":"pone.0356008.ref013","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0356008.ref014","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B: Stat Methodol"},{"key":"pone.0356008.ref015","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"H Wickham","year":"2016"},{"key":"pone.0356008.ref016","volume-title":"ggraph: An implementation of grammar of graphics for graphs and networks. R package version 2.2.2","author":"TL Pedersen","year":"2025"},{"key":"pone.0356008.ref017","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3389\/fimmu.2018.01852","article-title":"The critical role of chemokine (C-C Motif) receptor 2-positive monocytes in autoimmune cholangitis","volume":"9","author":"D Reuveni","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"pone.0356008.ref018","article-title":"Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis","volume":"18","author":"HN Pham","year":"2023","journal-title":"PLoS One"},{"issue":"6633","key":"pone.0356008.ref019","doi-asserted-by":"crossref","DOI":"10.1126\/science.abp8964","article-title":"The extracellular matrix and the immune system: a mutually dependent relationship","volume":"379","author":"TE Sutherland","year":"2023","journal-title":"Science"},{"issue":"6","key":"pone.0356008.ref020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/brainsci12060687","article-title":"Immediate early gene c-fos in the brain: focus on glial cells","volume":"12","author":"F Cruz-Mendoza","year":"2022","journal-title":"Brain Sci"},{"issue":"3","key":"pone.0356008.ref021","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100204","article-title":"Gut dysbiosis is linked to severe steatosis and enhances its diagnostic performance in MASLD","volume":"3","author":"M Borges-Canha","year":"2025","journal-title":"eGastroenterology"},{"issue":"3","key":"pone.0356008.ref022","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100199","article-title":"Clinical association between inflammatory bowel disease and primary sclerosing cholangitis: what changes after colectomy and liver transplantation?","volume":"3","author":"S Wang","year":"2025","journal-title":"eGastroenterology"},{"issue":"1","key":"pone.0356008.ref023","doi-asserted-by":"crossref","first-page":"2383353","DOI":"10.1080\/19490976.2024.2383353","article-title":"The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC","volume":"16","author":"H Jiang","year":"2024","journal-title":"Gut Microbes"},{"issue":"2","key":"pone.0356008.ref024","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100186","article-title":"Epigenetic mechanisms involved in hepatocellular carcinoma development and progression","volume":"3","author":"B Bueloni","year":"2025","journal-title":"eGastroenterology"},{"issue":"7","key":"pone.0356008.ref025","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"WJ Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0356008.ref026","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"M Carbone","year":"2016","journal-title":"Hepatology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:30:46Z","timestamp":1786642246000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356008"}},"subtitle":[],"editor":[{"given":"Lanlan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356008","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}